Stay updated on SAR425899 Safety in Overweight Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the SAR425899 Safety in Overweight Type 2 Diabetes Clinical Trial page.

Latest updates to the SAR425899 Safety in Overweight Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedAdded revision v3.4.3 to the record history. Removed revision v3.4.2 from the history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added; old funding/operating status notices were removed.SummaryDifference0.8%

- Check41 days agoChange DetectedA government funding notice banner was added and the site revision label updated to v3.4.1 (v3.4.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check48 days agoChange DetectedNon-substantive UI changes were introduced (glossary toggle, color-coded indicators for additions and deletions, and version label updated to v3.4.0) and no substantive study record data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check84 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the history, and the footer items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check113 days agoChange DetectedRecord History shows a new revision v3.3.2 and the removal of v3.2.0 in the Study Record Versions, reflecting a metadata update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SAR425899 Safety in Overweight Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR425899 Safety in Overweight Type 2 Diabetes Clinical Trial page.